← Back to patent-cliff list
MOTS-c
Tier C — Watch / tradeMOTS-c
Hudson Biotech
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Overweight, Obesity, 糖尿病前期, Insulin resistance
Regional status
US
-
EU
-
China
Phase II
2026-02-02
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Also available in our peptide catalogue
Frequently asked questions
What are the approved indications of MOTS-c?
Approved indications include: Overweight, Obesity, 糖尿病前期, Insulin resistance.
When does the MOTS-c patent expire?
No public expiry year is available for MOTS-c yet; this page updates once verified.
How do I get a quote for MOTS-c intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29